About Ubiquitin carboxyl-terminal hydrolase 14
Ubiquitin carboxyl-terminal hydrolase 14 (USP14) is a protein
from Homo sapiens identified by UniProt accession
P54578, 494 residues long.
MolForge cross-references it against 0 known binders and
281 disease associations.
Target properties
| Protein name | Ubiquitin carboxyl-terminal hydrolase 14 |
| UniProt accession | P54578 |
| Gene | USP14 |
| Organism | Homo sapiens |
| Length | 494 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (281)
Diseases linked to this target (Open Targets).
- vital capacity · score 0.35
- brain measurement · score 0.30
- age at menarche · score 0.28
- triglyceride measurement · score 0.24
- low grade glioma · score 0.23
- ovarian cancer · score 0.23
- high density lipoprotein cholesterol measurement · score 0.20
- body height · score 0.17
- smoking status measurement · score 0.15
- smoking behavior · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P54578-F1 | alphafold | PREDICTED | 81.92 | — |
Amino-acid sequence (494 residues)
MPLYSVTVKW GKEKFEGVEL NTDEPPMVFK AQLFALTGVQ PARQKVMVKG GTLKDDDWGN IKIKNGMTLL MMGSADALPE EPSAKTVFVE DMTEEQLASA MELPCGLTNL GNTCYMNATV QCIRSVPELK DALKRYAGAL RASGEMASAQ YITAALRDLF DSMDKTSSSI PPIILLQFLH MAFPQFAEKG EQGQYLQQDA NECWIQMMRV LQQKLEAIED DSVKETDSSS ASAATPSKKK SLIDQFFGVE FETTMKCTES EEEEVTKGKE NQLQLSCFIN QEVKYLFTGL KLRLQEEITK QSPTLQRNAL YIKSSKISRL PAYLTIQMVR FFYKEKESVN AKVLKDVKFP LMLDMYELCT PELQEKMVSF RSKFKDLEDK KVNQQPNTSD KKSSPQKEVK YEPFSFADDI GSNNCGYYDL QAVLTHQGRS SSSGHYVSWV KRKQDEWIKF DDDKVSIVTP EDILRLSGGG DWHIAYVLLY GPRRVEIMEE ESEQ
Explore Ubiquitin carboxyl-terminal hydrolase 14 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets